247 related articles for article (PubMed ID: 32668692)
1. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.
Kaushal N; Gupta Y; Goyal M; Khaiboullina SF; Baranwal M; Verma SC
Pathogens; 2020 Jul; 9(7):. PubMed ID: 32668692
[TBL] [Abstract][Full Text] [Related]
2. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
[TBL] [Abstract][Full Text] [Related]
3. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2.
Saadat KASM
Gene Rep; 2022 Mar; 26():101512. PubMed ID: 35071824
[TBL] [Abstract][Full Text] [Related]
5. Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"?
Alouane T; Laamarti M; Essabbar A; Hakmi M; Bouricha EM; Chemao-Elfihri MW; Kartti S; Boumajdi N; Bendani H; Laamarti R; Ghrifi F; Allam L; Aanniz T; Ouadghiri M; El Hafidi N; El Jaoudi R; Benrahma H; Attar JE; Mentag R; Sbabou L; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
Pathogens; 2020 Oct; 9(10):. PubMed ID: 33050463
[TBL] [Abstract][Full Text] [Related]
6. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
Omotoso OE; Olugbami JO; Gbadegesin MA
Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.
Liang F
Viruses; 2023 May; 15(5):. PubMed ID: 37243278
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Mohammed MEA
Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
[TBL] [Abstract][Full Text] [Related]
9. Different mutations in SARS-CoV-2 associate with severe and mild outcome.
Nagy Á; Pongor S; Győrffy B
Int J Antimicrob Agents; 2021 Feb; 57(2):106272. PubMed ID: 33347989
[TBL] [Abstract][Full Text] [Related]
10. Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population.
Omotoso OE; Babalola AD; Matareek A
Beni Suef Univ J Basic Appl Sci; 2021; 10(1):11. PubMed ID: 33564691
[TBL] [Abstract][Full Text] [Related]
11. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
Laha S; Chakraborty J; Das S; Manna SK; Biswas S; Chatterjee R
Infect Genet Evol; 2020 Nov; 85():104445. PubMed ID: 32615316
[TBL] [Abstract][Full Text] [Related]
12. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
[TBL] [Abstract][Full Text] [Related]
13. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
Yuan F; Wang L; Fang Y; Wang L
Transbound Emerg Dis; 2021 Nov; 68(6):3288-3304. PubMed ID: 33207070
[TBL] [Abstract][Full Text] [Related]
14. Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2).
Kelta Wabalo E; Dukessa Dubiwak A; Welde Senbetu M; Sime Gizaw T
Infect Drug Resist; 2021; 14():2187-2192. PubMed ID: 34163183
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.
Sassi MB; Ferjani S; Mkada I; Arbi M; Safer M; Elmoussi A; Abid S; Souiai O; Gharbi A; Tejouri A; Gaies E; Eljabri H; Ayed S; Hechaichi A; Daghfous R; Gouider R; Khelil JB; Kharrat M; Kacem I; Alya NB; Benkahla A; Trabelsi S; Boubaker IB
Infect Genet Evol; 2022 Aug; 102():105300. PubMed ID: 35552003
[TBL] [Abstract][Full Text] [Related]
16. Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations.
Periwal N; Rathod SB; Sarma S; Johar GS; Jain A; Barnwal RP; Srivastava KR; Kaur B; Arora P; Sood V
Microbiol Spectr; 2022 Oct; 10(5):e0121922. PubMed ID: 36069583
[TBL] [Abstract][Full Text] [Related]
17. Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.
Magateshvaren Saras MA; Patro LPP; Uttamrao PP; Rathinavelan T
Zoonoses Public Health; 2022 Nov; 69(7):816-825. PubMed ID: 35614572
[TBL] [Abstract][Full Text] [Related]
18. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
Tomaszewski T; DeVries RS; Dong M; Bhatia G; Norsworthy MD; Zheng X; Caetano-Anollés G
Evol Bioinform Online; 2020; 16():1176934320965149. PubMed ID: 33149541
[TBL] [Abstract][Full Text] [Related]
19. Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches.
Shah A; Rehmat S; Aslam I; Suleman M; Batool F; Aziz A; Rashid F; Midrarullah ; Nawaz MA; Ali SS; Junaid M; Khan A; Wei DQ
Comput Biol Med; 2022 Feb; 141():105170. PubMed ID: 34968862
[TBL] [Abstract][Full Text] [Related]
20. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
Mishra D; Suri GS; Kaur G; Tiwari M
J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
